Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Tongtai Biological Pharmaceutical Technology is a Chinese biotechnology company specializing in the research, development, and manufacturing of veterinary biological products. As a subsidiary of Tecon Biology, the company focuses on high-tech vaccines for livestock, particularly swine. Its product portfolio includes vaccines for Classical Swine Fever, Pseudorabies, and other significant porcine diseases. The company operates advanced manufacturing facilities in Changzhou and contributes to the animal health sector through innovative vaccine technologies and large-scale production capabilities. Changzhou Tongtai utilizes modern suspension cell culture platforms to ensure high-quality and efficient vaccine production. The company plays a vital role in the disease prevention and control infrastructure of the Chinese animal husbandry industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Tongtai Biological Pharmaceutical Technology.